Treatment of severe and resistant hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage; D003000:Clonidine / Q000008:administration & dosage; D003981:Diazoxide / Q000008:administration & dosage; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D006973:Hypertension / Q000139:chemically induced / Q000178:diet therapy / Q000188:drug therapy* / Q000209:etiology; D007275:Injections, Intravenous; D007741:Labetalol / Q000008:administration & dosage; D008750:Methyldopa / Q000008:administration & dosage; D009599:Nitroprusside / Q000008:administration & dosage; D010352:Patient Dropouts; D014294:Trimethaphan / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D008750:Methyldopa; D014294:Trimethaphan; D003000:Clonidine; D003981:Diazoxide; D007741:Labetalol